TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT04700878

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Internet-based compassion course for stress managemant
Description: A five week long, structured self-help program with weekly reports to, and feedback from a compassion-focused (CFT) therapist over the Internet. Includes traditional CFT-methods for stress-related problems.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: General Internet-based cognitive behavioural course for stress management
Description: A five week long, structured self-help program with weekly reports to, and feedback from a cognitive-behavioral (CBT) therapist over the Internet. Includes traditional CBT-methods for stress-related problems.

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: General Internet-based cognitive behavioural course for stress management
Description: A five week long, structured self-help program with weekly reports to, and feedback from a cognitive-behavioral (CBT) therapist over the Internet. Includes traditional CBT-methods for stress-related problems.
Study: NCT06267521

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Stimulation in Lab
Description: Participants will sleep in the lab and undergo active TES-TI stimulation for approximately 10 hours per night.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Stimulation in Lab
Description: Participants will sleep in the lab and undergo active TES-TI stimulation for approximately 10 hours per night.
Study: NCT05500898

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DWP16001
Description: Tablets, Oral, multiple doses of DWP16001
Study: NCT06267521

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: MRI Scanner
Description: Imaging protocol will include: structural T1-weighted and T2-weighted images, resting-state functional MRI, task-based functional MRI, and multi-shell diffusion weighted MRI, total scan time will be approximately 2 hours

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: MRI Scanner
Description: Imaging protocol will include: structural T1-weighted and T2-weighted images, resting-state functional MRI, task-based functional MRI, and multi-shell diffusion weighted MRI, total scan time will be approximately 2 hours

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: MRI Scanner
Description: Imaging protocol will include: structural T1-weighted and T2-weighted images, resting-state functional MRI, task-based functional MRI, and multi-shell diffusion weighted MRI, total scan time will be approximately 2 hours
Study: NCT05500898

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DWC202204+DWC202205
Description: Tablets, Oral, multiple doses of DWC202204 and DWC202205 in combination
Study: NCT06339125

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Fall prevention algorithm
Description: Algorithm generates fall prevention alerts to nurses in real time, using evidenced based electronic health record information regarding changes in care that may suggest the need for additional fall prevention strategies

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Fall prevention algorithm
Description: Algorithm generates fall prevention alerts to nurses in real time, using evidenced based electronic health record information regarding changes in care that may suggest the need for additional fall prevention strategies

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Inspiren camera visualization
Description: The Inspiren computer camera visualization is an additional strategy for nurses to employ when there is a change in a patient's fall risk.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Inspiren camera visualization
Description: The Inspiren computer camera visualization is an additional strategy for nurses to employ when there is a change in a patient's fall risk.
Study: NCT06267521

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: MRI Scanner
Description: Imaging protocol will include: structural T1-weighted and T2-weighted images, resting-state functional MRI, task-based functional MRI, and multi-shell diffusion weighted MRI, total scan time will be approximately 2 hours
Study: NCT04800874

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BBP-418
Description: BBP-418 is being developed for the treatment of patients with Limb-Girdle Muscular Dystrophy Type 2I (LGMD2I) for which no approved therapy currently exists. It targets the molecular defect at the source by supplying excess substrate to the mutant enzyme thus boosting glycosylation of muscle α-dystroglycan. The BBP-418 drug product will be packaged in sachets and provided in a carton for in-clinic and at home use.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BBP-418
Description: BBP-418 is being developed for the treatment of patients with Limb-Girdle Muscular Dystrophy Type 2I (LGMD2I) for which no approved therapy currently exists. It targets the molecular defect at the source by supplying excess substrate to the mutant enzyme thus boosting glycosylation of muscle α-dystroglycan. The BBP-418 drug product will be packaged in sachets and provided in a carton for in-clinic and at home use.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BBP-418
Description: BBP-418 is being developed for the treatment of patients with Limb-Girdle Muscular Dystrophy Type 2I (LGMD2I) for which no approved therapy currently exists. It targets the molecular defect at the source by supplying excess substrate to the mutant enzyme thus boosting glycosylation of muscle α-dystroglycan. The BBP-418 drug product will be packaged in sachets and provided in a carton for in-clinic and at home use.
Study: NCT06150768

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Cobalt Chromium Removable Partial Denture
Description: The patient will receive Removable Partial Denture to restore missing teeth in Kennedy Class II cases.
Study: NCT05500898

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DWP16001+DWC202204+DWC202205
Description: Tablets, Oral, DWP16001 , multiple doses of DWC202204 and DWC202205 in combination
Study: NCT06150768

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Implant-Supported Porcelain-Fused-to-Metal-Fixed Partial Denture
Description: The patient will receive Implant-Supported Porcelain-Fused-to-Metal-Fixed Partial Denture to restore missing teeth in Kennedy Class II cases.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Implant-Supported Zirconia Fixed Partial Denture.
Description: The patient will receive Implant-Supported Zirconia Fixed Partial Denture to restore missing teeth in Kennedy Class II cases.
Study: NCT06386692

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: FCHVs-led community based educational physical activity intervention
Description: This intervention will be designed to promote physical activity among adults
Study: NCT06368323

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Choir singing
Description: The 12-week intervention will consist of 12 in-person choir-singing sessions (1 session/week, 1,5 h/session, total 18h) conducted by a choir master in addition to home training (3 x 30-minutes-sessions/week, total 18h). In total, participants will undergo the intervention for 3 hours/week for 12 weeks (i.e., 36 hours).

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Choir singing
Description: The 12-week intervention will consist of 12 in-person choir-singing sessions (1 session/week, 1,5 h/session, total 18h) conducted by a choir master in addition to home training (3 x 30-minutes-sessions/week, total 18h). In total, participants will undergo the intervention for 3 hours/week for 12 weeks (i.e., 36 hours).

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Usual care
Description: Rehabilitation services received by patients and social activities will be monitored and documented.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Usual care
Description: Rehabilitation services received by patients and social activities will be monitored and documented.
Study: NCT06276452

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Psychoeducation
Description: Psychoeducation is the therapeutic management of illness through the increase of related knowledge, skills, and motivation.
Study: NCT05189522

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Innova Breeze®-based roadmap
Description: An Innova Breeze® bolus chase acquisition is realized to assess the final result of the Revascularization of the target limb. Both Innova Breeze® bolus chases are required at field of view 30-cm

Intervention type: OTHER
Group type: OTHER
Intervention: Control Group
Description: 2D roadmap guidance is used based on DSA. The treatment of the target lesion is let at the physician discretion. Treatment result of each lesion is checked by a DSA with 1 incidence.~After treatment overall limb assessment will be done through multiple staged DSA.~Finally, the sheath is retrieved and the hemostasis at the puncture site is realized via a manual compression or using a vascular closure device.~DSAs are performed with the injector set at 7mL/s and the volume at 7mL (pressure limit 1000psi) for femoropopliteal assessment. An injector with iodinated contrast (50% of dilution) will be used.~For hospitalized patients, three to five days after the procedure, a blood test is performed to assess the eGFR, as part of the usual care of patients. If the patient is no longer hospitalized, at the time of this examination, the investigating physician has given him an order before his discharge to perform this examination in an analysis laboratory.
Study: NCT05967923

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Shock wave therapy
Description: Patients in this group will receive shock wave therapy once a week for four weeks in addition to routine physical therapy program.

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Low level lazer therapy
Description: Patients in this group will receive low level lazer therapy three times a week week for four weeks in addition to routine physical therapy program.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Routine physical therapy program
Description: Patients in this group will receive only routine physical therapy program three times a week for four weeks.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Routine physical therapy program
Description: Patients in this group will receive only routine physical therapy program three times a week for four weeks.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Routine physical therapy program
Description: Patients in this group will receive only routine physical therapy program three times a week for four weeks.
Study: NCT01224652

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Paclitaxel
Description: Paclitaxel, 70 mg/m2 will be administered as an intravenous (IV) infusion over 1 hour on Days 1, 8 and 15 of a 28-day cycle

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Irinotecan
Description: irinotecan 150 mg/m2 will be administered as an intravenous (IV) infusion over 1 hour on Days 1 and 15 of a 28-day cycle
Study: NCT04309565

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Transitions Clinic Network Primary Care
Description: Transitions Clinic Network (TCN)- participants in this arm will be referred to a TCN program for primary care and community Opioid Treatment Program (OTP). All TCN programs have the ability to prescribe buprenorphine and Extended-release naltrexone (XR-NTX) and assist with referrals to methadone. The primary features of the TCN include (1) primary care and onsite MOUD or referral to community treatment when indicated, (2) addressing social determinants of OUD and care coordination through a Community Health Worker (CHW), and (3) addressing the discrimination and stigma that exist based on incarceration.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Standard Primary Care
Description: Those randomized to the standard primary care arm will be referred to primary care and community Opioid Treatment Program (OTP). Participants may receive buprenorphine or Extended-release naltrexone (XR-NTX) through primary care or with a community addiction treatment provider.
Study: NCT06536088

Intervention type: OTHER
Intervention: Walking assesment
Description: Spatiotemporal walking assessments are performed using the Gait Analyzer app (version 0.9.95.0) on a smartphone. Participants who can walk independently without assistance walk a 25-meter path at their normal speed, with the smartphone securely attached to their body above the third lumbar vertebra using a belt. The app records gait velocity, cadence, step time, step length, and vertical center of mass for all participants.

Intervention type: OTHER
Intervention: Walking assesment
Description: Spatiotemporal walking assessments are performed using the Gait Analyzer app (version 0.9.95.0) on a smartphone. Participants who can walk independently without assistance walk a 25-meter path at their normal speed, with the smartphone securely attached to their body above the third lumbar vertebra using a belt. The app records gait velocity, cadence, step time, step length, and vertical center of mass for all participants.
Study: NCT06308757

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Very-low-calorie ketogenic diet (VLCKD) with meal replacements
Description: The VLCKD study arm will receive an experimental diet therapy with very-low-calorie ketogenic meal replacements (VLCKD) consisting of 5 successive phases (600 - 1500 kcal/day).

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Mediterranean low-calorie diet (LCD)
Description: The Control arm LCD will receive standard Mediterranean type low-calorie diet (LCD) therapy by the most recent guidelines on MAFLD/NAFLD (1200-1500 kcal/day).
Study: NCT06301009

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: AI-CAC score
Description: Deep-learning based prediction of the coronary artery calcium score with a plain chest x-ray
Study: NCT05322356

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Interstitial Brachytherapy of the Prostate With Iodine 125 Implant With Target Dose Supplementation in the Tumor Volume Guided by the TRINITY® PERINE 3D
Description: Target dose supplement with the TRINITY® PERINE 3D system
Study: NCT05580328

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Hematoporphyrin Injection actived by photodynamic therapy combined with Sonodynamic Therapy
Description: Hematoporphyrin in tumor tissue will be greatly enhanced by the combination of Sonodynamic Therapy and Photodynamic Therapy and achieve better treatment effect.
Study: NCT05306522

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Spinal stabilization exercise
Description: The effects of telerehabilitation based spinal stabilization exercise in chronic stroke patients will be investigated.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Spinal stabilization exercise
Description: The effects of telerehabilitation based spinal stabilization exercise in chronic stroke patients will be investigated.
Study: NCT05811078

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: training sessions with peer interactive group
Description: Data were collected with data collection forms consisting of  Diabetes Adolescent Diagnosis Form, Diabetes Information Evaluation Form, Diabetes Management Self-Efficacy Scale in Adolescents with Type 1 Diabetes and Child's Attitude towards Own Disease Scale .
Study: NCT04719130

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Multimodal circuit exercise
Description: A structured and supervised multimodal exercise circuit twice a week, under 12 weeks program. The circuit workout program consists of 8 exercises, divided into motor coordination, balance, strength, and aerobic exercises. The exercises will be employed in a reserved room inside of the Basic Health Units. The sessions of exercises will last approximately 50 minutes,

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Multidisciplinary lectures
Description: Multidisciplinary lectures on pain and usual care provided by the Basic Health Units. A cycle of multidisciplinary lectures on pain will be offered by professionals in physical education, nursing, physiotherapy, medicine, psychology and social work that will take place in the Basic Health Units every 15 days.
Study: NCT05926752

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: SoLá therapy
Description: SoLá therapy is a photobiomodulation device that works by stimulating mitochondria, soothing tense muscles, and promotes healing.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Pelvic floor physical therapy
Description: Physical therapy is manual myofascial release, muscles stretches, and exercises designed to help myofascial pelvic pain
Study: NCT06125340

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: 5 days of placebo to be given after 3-5 days of antibiotics

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Amoxicillin
Description: Standard-dose amoxicillin (approved by Health Canada) to be given x 5 days.
Study: NCT06436755

Intervention type: PROCEDURE
Intervention: no intervention,this is a observational studies
Description: no intervention,this is a observational studies

Intervention type: PROCEDURE
Intervention: no intervention,this is a observational studies
Description: no intervention,this is a observational studies
Study: NCT06298357

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Immediate Start - Virtual Reality
Description: Participants will use a Meta Quest virtual reality headset and play video games for exercise and mindfulness. They will start using the headsets in the hospital and then will continue to do so for 8 weeks after hospital discharge.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Delayed Start - Virtual Reality
Description: Participants will receive usual care in the hospital and outside of the hospital for 8 weeks. After the 8 week post-discharge period, participants will use a Meta Quest virtual reality headset and play video games for exercise and mindfulness for an 8 week period.
Study: NCT06433934

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Oxy2mask
Description: Open design oxygen mask
Study: NCT06018545

Intervention type: OTHER
Intervention: Ground truthing
Description: Two Consultant neuroradiologists will independently review the images to establish the 'ground truth' findings on the CT scans which will be used as the reference standard. In the case of disagreement, a third senior neuroradiologist's opinion will be sought for arbitration.

Intervention type: OTHER
Intervention: Reading
Description: All 30 readers will review all 150 cases, in each of two study phases. The readers will provide their opinion on the presence or absence of some acute abnormalities, including intracranial haemorrhage, infarct, midline shift and fracture. They will provide a confidence in their diagnosis (10-point visual analogue scale), and a single click point to mark the location of each abnormality that they consider as being present. The time taken for each scan will be automatically recorded.
Study: NCT05216458

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Emails and letter intervention
Description: Emails and letters for households assigned to the treatment group

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Emails and letter intervention
Description: Emails and letters for households assigned to the treatment group

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Control group
Description: No outreach during the intervention period.
Study: NCT05800496

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: SesZen-Bio™
Description: mode of usage: 1 capsule in the morning and 1 capsule at night. administration: Oral Administration

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Mode of Usage: 1 capsule in the morning and 1 capsule at night. Route of Administration: Oral Administration
Study: NCT06133868

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Lavender and Chamomile Essential Oils
Description: essential oils

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Lavender and Chamomile Essential Oils
Description: essential oils

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Lavender and Chamomile Essential Oils
Description: essential oils
Study: NCT06191861

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Most hoped for future self
Description: Participants in this condition complete a version of the future possible self task in which they think and write about their most hoped for future self for 20 minutes.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Most hoped for future self
Description: Participants in this condition complete a version of the future possible self task in which they think and write about their most hoped for future self for 20 minutes.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Most feared future self
Description: Participants in this condition complete a version of the future possible self task in which they think and write about their most feared future self for 20 minutes.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Most feared future self
Description: Participants in this condition complete a version of the future possible self task in which they think and write about their most feared future self for 20 minutes.

Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Control (trip to zoo)
Description: Participants in this condition think and write about a future trip to the zoo

Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Control (trip to zoo)
Description: Participants in this condition think and write about a future trip to the zoo

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Balanced future self
Description: Participants in this condition complete a version of the future possible self task in which they think and write about their most hoped for and feared future self for 20 minutes.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Balanced future self
Description: Participants in this condition complete a version of the future possible self task in which they think and write about their most hoped for and feared future self for 20 minutes.
Study: NCT04737005

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Nano-ceramic hybrid (Grandio Blocs) Endo-crown
Description: Nano-ceramic hybrid

Intervention type: PROCEDURE
Group type: OTHER
Intervention: Nano-ceramic hybrid (Grandio Blocs) Endo-crown
Description: Nano-ceramic hybrid
Study: NCT05238363

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HLX07
Description: HLX07 1500mg ivgtt Q3W